Review and provide recommendations to adopt and implement new terms and codes proposed by World Health Organization (WHO) in newly released editions of the Classification of Tumors (blue books) and ICD O 4.
The Pathology Reporting WG is developing additional guidance in Standards Volume V to address reporting of original pathology report information with biomarker and molecular laboratory test data.
The Pediatric Site-Specific Data Item Work Group (Ped SSDI WG) oversees the development and maintenance of cancer registry pediatric data items recommended or required for collection for one or more cancer sites/histologies/schemas.